Homoeopathy as an add-on in treatment of COVID-19
Phase 2
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026195
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Hospitalized symptomatic patients with COVID-19 infection
2.Age between 18 years to 80 years
3.Both the sexes
4.Willing to give written informed consent
Exclusion Criteria
1.Severe heart, lung, kidney, brain, blood diseases or other important systemic diseases
2.Patients on ventilatory support
3.Immunocompromised patients
4.Subjects considered to be unable to complete the study, or not suitable for the study by researchers.
5.Women during pregnancy.
6.Lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method